Lexicon Pharmaceuticals
  • Home
  • Contact Us
  • Site Map
  • About Us
    • About Us Home
    • Management Team
    • Board of Directors
    • Development Team
    • Locations
    • Contact Us
    • History
  • Pipeline
    • Drug Pipeline Home
    • Our Goal
    • Therapeutic Areas
    • Drug Development Team
    • Clinical Trials
    • Publications
  • Discovery
    • Discovery Home
    • Discovery Process
    • Technology
    • Genome5000
    • Medicinal Chemistry
    • Biotherapeutics
    • Patents
    • Academic Access
    • Technology Licensing
  • Alliances
    • Alliances Home
    • Current Alliances
    • Technology Licensing
  • Careers
    • Careers Home
    • Opportunities
    • Our Culture
    • Benefits
    • Community Involvement
    • The Woodlands
    • Princeton
    • Awards and Recognition
  • News
    • News Home
    • Media Inquiries
  • Investors
    • Investors Home
    • Media
    • Events
    • Stock Quote
    • SEC Filings
    • Annual Reports
    • Corporate Governance
    • Request Information
Lexicon Banner
  • News Home
  • Media Inquiries
Subscribe
Press Releases
Filter     Display # 
04/22/2003 Lexicon Genetics Licenses Patented Gene Targeting Technology to Aventis Pharmaceuticals
04/21/2003 Lexicon Genetics Announces Webcast of Presentation at the CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference
04/17/2003 Lexicon Genetics to Hold First Quarter 2003 Financial Results Webcast And Conference Call
03/25/2003 Lexicon Genetics Appoints Alan S. Nies, M.D. Chairman of the Medical Advisory Board
03/19/2003 Lexicon Genetics Extends OmniBank(R) Universal Agreement With Boehringer Ingelheim Pharmaceuticals Inc.
02/25/2003 Lexicon Genetics Discovers Novel Target for the Development of Treatments for Osteoporosis
02/21/2003 Lexicon Genetics Announces Webcast of Presentation at the BIO CEO & Investor Conference 2003
02/19/2003 Lexicon Genetics Reports 2002 Fourth Quarter and Full Year Financial Results; Revenues Increased 15% in 2002
01/30/2003 Lexicon Genetics to Hold Fourth Quarter and Year End 2002 Financial Results Webcast and Conference Call
01/08/2003 Lexicon Genetics Extends OmniBank(R) Universal Agreement With Johnson & Johnson Pharmaceutical Research & Development, L.L.C
 
«StartPrev11121314151617181920NextEnd»
Page 20 of 32
  • About Us
  • Pipeline
  • Discovery
  • Alliances
  • Careers
  • News
  • Investors
  • Terms Of Use

Copyright © 2008, Lexicon Pharmaceuticals, Inc. All rights reserved.